Funded by the NIH HEAL Initiative℠
The objectives of this study examine factors potentially limiting or/and facilitating MAT utilization in DC clinics (Study 1) and identifying and targeting missed opportunities for outreach and engagement of patients with OUD in overdose prevention and MAT (Study 2) to develop approaches to address these overdose prevention and treatment gaps in DC OUD treatment system.
CTN Protocol ID:
CTN-0088
Status:
Completed
ClinicalTrials.gov ID:
Principal Investigator(s)
Richard Schottenfeld, MD
Chair, Department of Psychiatry and Behavior Health
Howard University
2041 Georgia Avenue, NW
Washington, DC 20060
United States